The letter goes on to say that “these violations are concerning from a public health perspective because they suggest that Metozolv ODT is safer and more effective than has been demonstrated by substantial evidence or substantial clinical experience, and encourage use in circumstance other than those for which the drug has been shown to be safe and effective.”

The FDA approved Metozolv in September for the treatment of GERD, gastroparesis, and other acid reflux conditions. It is the first fast-dissolving version of metoclopramide, a drug also known by the brand name Reglan. Its projected annual sales could reach $50 million.

Last year the FDA ordered a black box warning be placed on Reglan after numerous reports of a serious involuntary movement disorder known as Tardive Dyskinesia developing in patients who took Reglan. The same black box warning was to be placed on Metozolv when it became available in the U.S. However, upon review, the FDA says Salix fell short of adequately warning patients of the risks associated with Metozolv.

The FDA is ordering Salix to immediately stop the dissemination of the violative promotional materials for Metozolv and to submit a written response to its warning letter explaining how the company will comply with the agency’s request. Failure to correct the violations could result in regulatory action, including seizure or injunction without further notice.

SOURCE: Reglan Side Effects › FDA warns makers of acid reflux drug to change warning label

GERD is chronic heartburn, a condition caused when food or liquid travels backwards from the stomach to the esophagus causing a burning sensation in the throat or chest. It can be bothersome to adults, and cause problems for infants, making them irritable and unwilling to eat.

As many as 70 percent of all babies spit up on occasion, which is normal and doesn’t require treatment. The number of infants who actually suffer from GERD is thought to be as low as five percent. Yet, diagnosing irritable babies with GERD seems to be the trend, says Dr. Eric Hassal, a gastroenterologist at the B.C. Children’s Hospital in Vancouver. And that can lead to over-prescribing of medication that some argue has not been sufficiently studied, especially in pediatric patients.

“Now everybody’s saying, ‘Oh, they must have reflux because they are spitting up. And we’ve got these great brand new drugs that we should give your baby’,” Dr. Hassall told CTV News.

While medication is a viable treatment for people who suffer from heartburn and GERD symptoms, like all medications, they should be taken with caution. For example, one common GERD medication prescribed for both adult and pediatric patients, Reglan (metoclopramide), recently received a black box warning by the FDA after numerous patients who took the drug reported suffering from a serious debilitating movement disorder known as Tardive Dyskinesia.

That is one reason why Dr. Hassal recommends parents first take a non-medicinal approach to treating their babies who appear to be suffering from symptoms of GERD, which includes keeping the baby in an upright position for as long as possible after meals, avoiding tobacco smoke, swaddling the baby, and carrying the baby in a carrier close to your body. Diet changes and better burping practices can also help improve symptoms.

SOURCE: Reglan Side Effects › GERD a trendy diagnosis for fussy infants

One popular choice in acid reflux treatment are pills known as Proton-Pump Inhibitors. “The dark side of Proton-Pump Inhibitors, because we’ve used so much of them for such a long period of time, is beginning to emerge,” says Dr. Henri Roca of LSU Health Sciences Center’s Family and Integrative Medicine during a interview with WWL-TV in New Orleans.

Proton-Pump Inhibitors are available both by prescription, such as Nexium, and over-the-counter, as Prevacid, Omeprazole and Prilosec. These drugs are recommended for use for seven or eight weeks. When someone takes them for 12 weeks or longer, problems arise.

When taken long term, Proton-Pump Inhibitors can inhibit the body from properly absorbing calcium, which puts long-term users at high risk for osteoporosis. It also interferes with the body’s defense mechanisms by clearing up bacteria that benefits the stomach and intestines, thus contributing to more gastrointestinal infections. And recently, the Food and Drug Administration (FDA) issued a warning about the combined use of the heart medication Plavix with Proton-Pump Inhibitors after tests showed that the Proton-Pump Inhibitors reduced the effectiveness of Plavix.

Another type of medication used to treat heartburn symptoms available only by prescription is Reglan (metoclopramide). Again, long-term (12 weeks or more) use of Reglan can have serious consequences. Early this year the FDA issued a black box warning on Reglan and other metoclopramide medications after numerous cases of a serious movement disorder known as Tardive Dyskinesia had been linked to use of Reglan. Tardive Dyskinesia can be debilitating and the symptoms may not stop even after the medication has been discontinued.

Doctors advise patients to talk with the doctors about their symptoms and any medications they may be taking. According to Dr. Roca, your symptoms may be caused by a number of ailments, and there may be safer and more effective ways to treat your heartburn symptoms.

SOURCE: Reglan Side Effects › Long term use of heartburn drugs can be dangerous

Another chronic sneezer, 22-year-old Caileen Wendel of Pennsylvania, says she sympathizes with Johnson because she has suffered from the same sneezing symptoms for five years. Doctors were also baffled by her condition and after 40 emergency room visits, Wendel finally found a doctor willing to try something new. Dr. Larry Geisler with St. Mary’s Hospital in Langhorne, Pa., prescribed the anti-nausea drug Reglan (metoclopramide) with Benedryl. Within five minutes, Wendel’s sneezing stopped.

“I don’t know if it’s a fix-all, but it happened to work and it worked for Caileen,” Dr. Geisler told NBC Philadelphia. It is a blessing that Wendel’s treatment is working, giving her life back. “To be able to stop something that I have no control over is probably one of the best feelings in the world,” she said. Both Wendel and Dr. Geisler hope that the same combination of medications can help Johnson.

Wendel says her symptoms return from time to time, and when they do she gets back on the combined Reglan-with-Benedryl meds and the sneezing stops. But, staying on the drug long term is not an option for Wendel. While Benedryl is available over-the-counter, Reglan requires a prescription, and carries a black box warning, issued earlier this year by the Food and Drug Administration (FDA). The warning was issued after the FDA received numerous reports of a serious movement disorder known as Tardive Dyskinesia in people who had taken Reglan. Studies have shown that people who take the drug for more than 12 weeks are as much as 20 percent at risk for developing the condition.

SOURCE: Reglan Side Effects › Reglan may calm chronic sneezing fits, but long-term use risky

The patient suffers fro gastroparesis, a condition in which the stomach empties its contents too slowly. It often affects people with diabetes. However, in as many as 60 percent of children with the condition, the cause is unknown.

The procedure involves inserting the pacemaker into the abdomen and placing the electrical wires attached to the device on the stomach. Electrical impulses stimulate the stomach after eating, encouraging the stomach to empty its contents.

“The initial settings are fairly low and, as with a pacemaker in the heart, we can change the settings as needed,” said pediatric surgeon Steven Teich, MD, surgical director of the Bariatric Surgery Program at Nationwide Children’s Hospital and clinical assistant professor of surgery at The Ohio State University College of Medicine.

Pacemakers have been used to treat gastroparesis in adults and results have been promising. “In patients who have received this type of treatment, nearly all symptoms were resolved within two weeks,” said said pediatric gastroenterologist Hayat Mousa, MD, medical director of the Motility Center at Nationwide Children’s Hospital and Associate Professor of Clinical Pediatrics at The Ohio State University College of Medicine.

The procedure takes the place of other, less effective treatments, commonly the medication metoclopramide known in the U.S. by the brand name Reglan. Reglan can only be used for short terms, as long-term use has been linked to a serious and debilitating involuntary movement disorder known as Tardive Dyskinesia. Earlier this year, the Food and Drug Administration (FDA) placed a black box warning on the medication alerting patients and health care professionals of the serious risk when using the medication for more than 12 weeks.

Other medications used to treat gastroparesis include antibiotics, which also carry a list of side effects. “None of these options are really that effective. Hence, the need for better treatment with the gastric pacemaker,” says Dr. DiLorenzo, Chief of Gastroenterology at Nationwide Children’s Hospital.

Source: DotMed News

SOURCE: Reglan Side Effects › Procedure shows promise versus drugs for children with gastroparesis

Earlier this year the Food and Drug Administration (FDA) issued a black box warning on Reglan to warn of the increased risk of the movement condition known as Tardive Dyskinesia. The condition is more pronounced in individuals who take the medication for more than 12 weeks. Tardive Dyskinesia is identified by involuntary movements of the muscles that include eye blinking and bulging, head jerking, lip smacking, tongue thrusting, facial grimacing, puckering and pursing of the lips and involuntary movements of the fingers.

The condition may be permanent even after the medication has been stopped. The medication also may mask the symptoms of the condition, which often get worse after the drug is discontinued.

While the elderly are most at risk, children, like Joey, can suffer serious side effects as well. “My son has been through a lot. He has had problems at school and has had a lot of other children asking him why do you blink your eyes and jerk your head. He has been to many doctors and put on several types of medicines. He has also been diagnosed with severe anxiety, which is also a side effect of this drug,” his mother says. “I would advise anyone taking this drug to stop immediately! The side effects are permanent and are very life altering. This drug is dangerous and the FDA needs made responsible for all the sufferers out there. Don’t let the FDA fool you…they have known about these symptoms since 1984…I have done my research!”

* names have been changed

SOURCE: Reglan Side Effects › Reglan side effects leave young boy with serious movement disorder

HD symptoms include changes in personality, cognition and physical skills. Almost all patients with HD exhibit physical symptoms such as jerky, random and uncontrollable movements. Many HD patients who were prescribed Reglan “have experienced not only symptoms of neuroleptic malignant syndrome (NMS) and/or Tardive Dyskinesia, but (also) hallucinations, paranoia, suicidal thoughts, severe anger outburts, etc.,” according to Jean E. Miller, a contributor editor for HD Lighthouse, an information center and community for patients with HD and their family members. “In one HD patient, the serious side effects still hadn’t gone away 18 months after taking Reglan.”

Earlier this year the Food and Drug Administration ordered the makers of Reglan (metoclopramide) to include a black box warning on the product label warning of the risk of Tardive Dyskinesia with long-term, high-dose use of the drug. Tardive Dyskinesia is a condition in which the body moves repetitively and uncontrollably. The condition often continues even after the medication has been discontinued.

Miller says she hopes the black box warning on Reglan will make physicians more cautious when prescribing the medication for patients with HD. She also urges familys of HD patients to “exercise caution when a physician wants this medication prescribed, especially for those in the later stages of HD or on feeding tubes.”

SOURCE: Reglan Side Effects › Tardive dyskinesia in Huntington disease patients on Reglan

Gastroparesis

Diabetes can cause damage the vagus nerve when blood glucose levels remain high over a long period of time by damaging the blood vessels that carry oxygen and nutrients to the nerves. According to the American Diabetes Association, symptoms of gastroparesis include heartburn, nausea, vomiting of undigested food, an early feeling of fullness when eating, weight loss, abnormal bloating, erratic blood glucose levels, lack of appetite, gastroesophageal reflux or spasms of the stomach wall.

Gastroparesis is often treated by managing blood glucose levels as best as possible through insulin, oral medications or a change in diet. Medications also can be prescribed to help encourage digestion, such as metoclopramide, known by the brand name Reglan.

As with any medication, patients should be aware of any adverse reactions they experience while taking medication, and this is especially true with Reglan (metoclopramide). Earlier this year the Food and Drug Administration (FDA) issued a black box warning, the stiffest warning the FDA can require, after studies have shown that people taking metoclopramide can develop a serious condition known as Tardive Dyskinesia, in which a person develops involuntary movements of their muscles, particularly of the face and fingers.

Patients taking Reglan (metoclopramide) should consult their health care provider if they experience any adverse reactions to the medication. If you have been injured by Reglan (metoclopramide) side effects, you may have a claim against the manufacturer.

SOURCE: Reglan Side Effects › Patients with gastroparesis should weigh treatment options

Kecia Neal

Last month, Neal filed suit against Teva Pharmaceutical, Schwarz Pharma and Wyeth Inc., makers of Reglan and its equivalent metoclopramide, after she began experiencing involuntary and repetitive movements of her body and face known as tardive dyskinesia. The condition is debilitating, and often continues even after the medication has been discontinued.

In February 2009, the Food and Drug Administration (FDA) ordered Reglan’s manufacturers to provide an additional boxed warning that “chronic treatment with metoclopramide can cause tardive dyskinesia, a serious movement that is often irreversible.” The new warnings state that “prolonged treatment (greater than 12 weeks) with metoclopramide should be avoided in all but rare cases,” however those warnings came far too late for Neal.

According to the lawsuit, patients who take Reglan for more than 12 weeks are at a 100 times greater risk for developing the disorder and other side effects.

Neal, who was on Reglan for more than a year, says she did not have access to the warnings about taking Reglan long-term. As a result, she is suffering from permanent and debilitating injuries. The lawsuit seeks damage for past and future medical expenses, physical pain and suffering, mental anguish, physical disfigurement, physical impairment, disability, psychological injury, loss of ability to provide household services, loss of earnings, and loss of earning capacity.

The case is expected to become part of a multi-district litigation.

Source: Southeast Texas Record

SOURCE: Reglan Side Effects › Woman files suit against Reglan for causing serious movement disorder

“He has been sick ever since he was born,” writes Sam Weber. Karter was diagnosed with infantile spasms when he was just two months old, and has been on the medication Reglan for digestive problems since he was just two days old. He was recently taken off Reglan, and tested for West Syndrome, a seizure disorder, but the tests came out negative. “I have a feeling that he may have TD,” Sam Weber writes. “He continues to spasm and cry and stiffen up like he is in pain.”

The Weber’s concerns about Tardive Dyskinesia may be warranted. The Food and Drug Administration (FDA) recently issued a black box warning on Reglan and its generic metoclopramide after receiving reports that long-term use of the medication has been linked to an increased risk of Tardive Dyskinesia. Individuals with Tardive Dyskinesia develop involuntary movements of their muscles. Those movements include lip smacking, tongue thrusting, head jerking, facial grimacing, and involuntary movements of the fingers.

There is no known cure for Tardive Dyskinesia, and symptoms may persist even after the medication is discontinued.

SOURCE: Reglan Side Effects › Family asks, ‘Is this Tardive Dyskinesia?’

Shirley Brinkley was prescribed Reglan by her physician in 1992 to treat a stomach ailment. According to the complaint, her physician referred to the Physician’s Desk Reference (PDR) and the medication’s package inserts and prescribed the medication for long-term use. She took the medication until April 2007.

Brinkley claims that even though the Food and Drug Administration (FDA) had approved the long-term use of Reglan, taking the medication for the prolonged period caused her to suffer from uncontrolled movements associated with Tardive Dyskinesia. Because of the condition, she has and will continue to experience medical and related expenses, loss of ability to provide household services, disfigurement, disability, pain and suffering, and psychological injury.

“Because of the misleading information that the Defendants provided to physicians and the FDA about the true risks associated with the use of Reglan and because of the failure of the Defendants and each of them to adequately inform physicians generally, including Plaintiff’s physicians, about the true risks associated with the use of Reglan, her physicians never informed her of any side effects associated with Reglan or that Reglan was only approved for short term use (up to 12 weeks),” the complaint states.

Wyeth, A.H. Robins Company Inc., and Schwarz Pharma are named in the product liability suit.

Source: Madison-St. Clair The Record

SOURCE: Reglan Side Effects › Woman with Tardive Dyskinesia sues makers of Reglan

Questcor Pharmaceuticals Inc

Diabetes is just one of the known causes of gastroparesis. The condition is generally treated through dietary changes and medications including metoclopramide, which is commonly found under the brand names Reglan, Maxolon or Clopra and is traditionally available in the form of a tablet,  oral solution or injection.

The clinical trail on Questor’s Emitasol metoclopramide nasal spray showed encouraging results in terms of safety and preliminary evaluation of efficacy in the treatment of diabetic gastroparesis. No serious adverse events were reported during the trial.

In recent months, the Food and Drug Administration (FDA) placed a black box warning on the drug metoclopramide – the strongest warning required by the FDA – after a serious condition called Tardive Dyskinesia was reported in a number of patients who took the drug. Tardive Dyskinesia is a Parkinson’s-like condition in which a person develops involuntary movements of his muscles, including lip smacking, tongue thrusting, eye blinking and bulging, head jerking, facial grimacing, lip puckering and involuntary movements of the fingers. The condition can be permanent, even after the drug has been discontinued.

Questor says it plans to begin Phase III of the Emitasol study as soon as possible.

Source: PR Newswire

SOURCE: Reglan Side Effects › Clinical trial underway for metoclopramide nasal spray

Laura received a letter late last month from her GI’s office notifying her that the Food and Drug Administration (FDA) had placed a “Black Box Warning” on Reglan because it carried a risk of a rare but Parkinson’s-like condition known as known as Tardive Dyskinesia. There is no treatment for Tardive Dyskinesia, and it is often irreversible even after the medication has been discontinued.

Shortly after being prescribed Reglan (metoclopramide), Laura’s health began to decline. Her tongue started moving out of control and she began smacking her lips. She didn’t immediately make the connection between her condition and Reglan. When she contacted her physician and said she was experiencing tremors, he ordered her to cut the Reglan in half.

“Why didn’t my gastroenterologist warn me? Why didn’t he give me a choice?” she asks.

Even though she has stopped taking the medication, she still suffers from uncontrolled movements of her tongue, which cause sores on her tongue, lesions in her mouth and inflamed gums. “It’s nerve wracking,” she says. Even more concerning is that her pregnant daughter was given a prescription for Reglan to treat morning sickness. “She told (her doctor) ‘No way,’ recalling what happened to me.”

Patients who have taken Reglan in the past or are currently taking Reglan are advised to contact their health care provider even if they have not experienced any side effects from the medication. Negative side effects should be reported to the FDA online at www.fda.gov/medwatch, or by phone at 1-800-FDA-1088.

Source: RGJ.com

SOURCE: Reglan Side Effects › Woman harmed by Reglan wants to know why she was never warned

Warner Chilcott

Tardive Dyskinesia has been linked to types of antidepressants such as SSRIs (selective serotonin reuptake inhibitors) and SSNRs (serotonin-norepineprine reuptake inhibitors). It also was recently linked to gastrophageal reflux medication Reglan. Tardive Dyskinesia is often irreversible even after the drug has been discontinued.

PMDD, a condition associated with severe emotional and physical problems linked closely to the menstrual cycle, affects about 5 percent of menstruating women. Both PMDD and PMS share common symptoms such as depression, anxiety, tension, irritability and moodiness, however PMDD is far more severe. It is often treated with antidepressants and anti-anxiety drugs, such as those classified as SSRIs and SSNRs.

Sarafem is believed to correct the imbalance of serotonin that may contribute to PMDD. Although Sarafem is not a treatment for depression, it contains fluoxetine hydrochloride, the same active ingredient in some antidepressants. Like other SSRIs and SSNRs, Sarafem also carries a warning of suicidal thoughts and behavior.

Patients are advised to discuss with their doctor any side effects experienced while taking Sarafem. Negative side effects should be reported to the Food and Drug Administration (FDA) online at www.fda.gov/medwatch, or by phone at 1-800-FDA-1088.

SOURCE: Reglan Side Effects › PMDD medication linked to Tardive Dyskinesia

The FDA recently issued a boxed warning for Reglan after recent studies revealed that people on the medication can develop a serious Parkinsons-like condition called Tardive Dyskinesia.

Jennifer’s daughter only had three doses of the medication before Jennifer took her off the drug. She was never diagnosed with Tardive Dyskinesia, however the medication did cause her to become irritable and she started “flailing her arms, twitching with stiff movements and screaming uncontrollably,” Jennifer said. “As soon as we discontinued Reglan she went back to her normal behaviors.”

While Jennifer vowed to never use the drug again, she caved with her second daughter after her severe reflux nearly caused her to aspirate. The younger daughter didn’t have the same reaction to Reglan and the little girl stayed on the medication for more than a year. She did suffer developmental delays, which Jennifer’s pediatrician says was likely caused by the prolonged use of Reglan.

“I would NEVER presume to tell anyone whether to use Reglan or not,” Jennifer said. “What I will tell you is that this is not a medication that should be taken without doing research.”

Source: Health Central

SOURCE: Reglan Side Effects › Mother says FDA’s Reglan warning is long overdue

The drug is primarily used in infants to treat gastroesophageal reflux and in children and adults to treat heartburn or nausea and vomiting caused by other medications. But Reglan has a side effect of increasing the prolactin in the brain. Prolactin is the milk-making hormone. Coupled with frequent and regular breast pumping, Reglan has been shown to increase breast milk production. A small amount of the mother’s dose will transfer to her breast milk, but studies indicate that there have been no side effects to infants.

However, some reports of other, serious side effects from the use of Reglan have made breastfeeding advocates leery of the medication. Some mothers have reported feeling fatigued, irritable or depressed while taking the medication. Reglan is in a class of medications known as dopamine-blockers, which includes several antipsychotic and some antidepressants. The Food and Drug Administration (FDA) recently issued a black box warning to consumers and health care providers warning of the risk of a neurological disorder called tardive dyskinesia with the long-term or high-dose use of Reglan.

As an alternative medication to Reglan, breastfeeding experts recommend Motillium (domperidone), to increase breast milk production. Motillium does not pass the blood-brain barrier and as a result has fewer side effects.

Source: Breastfeeding Online

SOURCE: Reglan Side Effects › Breast milk-increasing medication linked to neurological disorder

Tardive dyskinesia is an often irreversible condition that is characterized by involuntary, repetitive movements of the extremities, or lip smacking, grimacing, tongue protrusion, rapid eye movements or blinking, puckering and pursing of the lips, or impaired movement of the fingers.

It is likely the Supreme Court decision will cost the pharmaceutical drug market “billions of dollars,” according to one attorney quoted by Bloomberg. “There’s no way to quantify it, but the number has as many zeroes in it as attacked Pearl Harbor.”

SOURCE: Reglan Side Effects › Supreme Court ruling could cost pharmaceutical industry ‘billions’

While several antipsychotic and some antidepressants have been linked to the condition, more drugs are being added to the list of possible culprits. Recently, the Food and Drug Administration (FDA) issued a black box warning to consumers and healthcare providers warning of the risk of tardive dyskinesia with the long-term or high-dose use of metoclopramide, more commonly known as Reglan, a medication prescribed for the treatment of disorders like heartburn caused by gastroesophageal reflux disease. Elderly patients, especially women, are at an increased risk of developing the condition while using Reglan.

The medicines that can cause tardive dyskinesia affect how nerve impulses are transmitted across gaps between nerve cells. This is done in part by blocking a chemical made by the body called dopamine. (Reglan is considered a dopamine receptor blocking agent.) Over time, the nerves seem to become hypersensitive to dopamine, causing abnormal movements.

There is currently no cure for the condition, however in some patients, symptoms may lesson or resolve after coming off the medication. The FDA has advised physicians to avoid long term use of Reglan except in rare cases where the benefit outweighs the risks.

SOURCE: Reglan Side Effects › Dopamine-blocking medications linked to tardive dyskinesia